Sarah Kim-McOlash - Concepedia

Author

Sarah Kim-McOlash

Also Known As

Sarah Kim, Sarah Kim-McOlash

Publications

226

Citations

H-Index

Concepts

All Affiliations

Sarah Kim-McOlash is an author at University of Minnesota specializing in pharmacotherapy, medicine, and patient safety.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	24
2	Pharmacology	1	1	24
3	Drug Monitoring	1	1	24
4	Drug Safety	1	1	24
5	Patient Safety	1	1	24

Sarah Kim-McOlash

Publications

206

Citations

H-Index

Page 1

	Year	Citations
Infantile gangliosidoses: Mapping a timeline of clinical changes Jeanine Utz, Sarah Kim-McOlash, Kelly King, Molecular Genetics and Metabolism	2017	84
A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I Li Ou, Michael J. Przybilla, Ozan Ahlat, Molecular Therapy	2020	57
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs Robert N. Schuck, Michael Pacanowski, Sarah Kim-McOlash, Clinical and Translational Science Drug SafetyNew DrugTitration RegimensPharmacologyPatient Safety	2019	24
The juvenile gangliosidoses: A timeline of clinical change Kelly King, Sarah Kim-McOlash, Chester B. Whitley, Molecular Genetics and Metabolism Reports	2020	16
Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling Li Ou, Sarah Kim-McOlash, Chester B. Whitley, Molecular Genetics and Metabolism Reports	2019	14
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma Sonia Singh, Diana Bradford, Somak Chatterjee, Clinical Cancer Research	2025	11

Page 1